The RFK Jr. Effect: Why GLP-1s Won't Be The Last 'Explosive' Story In Peptides
Detailed summary
Hims stock zoomed higher on a Health Department push to legalize six peptides. It could be just the beginning of a massive overhaul in health. The post The RFK Jr. Effect: Why…
Health Secretary Robert F. Kennedy Jr. calls himself a "big fan" of peptides. These injections lie in the blurry space between approved drugs and unvetted supplements but, thanks to fitness enthusiasts and wellness influencers, they've hit the mainstream — giving Hims stock a boost and promising to do everything from stoking weight loss to improving longevity. Now, RFK Jr. says…
Opening of the article, excerpted from Investor's Business Daily. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)
